Twist Bioscience

Abveris is a biotechnology company focused on the discovery of antibodies for both reagent and therapeutic applications. It provides contract research services to the biopharma industry, utilizing advanced immunization techniques along with B cell screening and hybridoma-based antibody discovery technologies. This comprehensive approach allows Abveris to support clients throughout the entire process of antibody discovery, from the initial project design and communication to the final delivery of products. By combining innovative methods with expertise in antibody development, Abveris aims to meet the diverse needs of its clients in the biopharmaceutical sector.

iGenomX is a biotechnology company focused on advancing clinical sequencing for recessive genetic disorders. Recognizing the limitations of existing commercial technologies, which often miss a significant portion of known causal mutations, iGenomX has developed innovative sample preparation technology aimed at enhancing DNA sequencing capabilities. Their approach emphasizes smarter next-generation sequencing (NGS) library construction, which not only improves the accuracy of genetic testing but also reduces costs and streamlines workflow for various applications, including population genetics, disease genetics, agricultural research, microbiome studies, and synthetic biology. Through its technology, iGenomX aims to provide comprehensive genetic data that can significantly benefit clinical and research settings.

Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers unique products and collaborative research and development services that aid in the discovery of new cell strains and molecules. Its cell analysis systems facilitate the screening and isolation of rare and valuable biological variants, catering to various applications in research, therapeutic development, bioproduction, and diagnostics. By streamlining these processes, Sphere Fluidics enables clients to reduce costs and time, thereby accelerating advancements in biological and biopharmaceutical discovery.

Genome Compiler Corporation is a software company that specializes in providing a comprehensive platform for genetic engineers and synthetic biologists. Founded in 2011 and based in Los Altos, California, the company offers an integrated software solution that facilitates DNA design, visualization, data management, and collaboration. Its flagship product, Genome Compiler, features advanced tools for designing and debugging biological code, allowing scientists in biotechnology, agriculture, and pharmaceuticals to streamline the creation of bio-based products. The platform supports users in editing whole genomes, ordering DNA syntheses from various providers, and collaborating securely in a cloud environment. Genome Compiler Corporation has positioned itself as a key player in the synthetic biology industry by making the programming of living organisms more accessible and efficient. In 2016, it became a subsidiary of Twist Bioscience Corporation.